Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding-Reference-Cited by-同舟云学术

Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding

Published:2019-02-05 Issue:6 Volume:139 Page:748-756
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Van der Wall Sake J.¹,Lopes Renato D.²,Aisenberg James³,Reilly Paul⁴,van Ryn Joanne⁵,Glund Stephan⁵,Elsaesser Amelie⁵,Klok Frederikus A.¹,Pollack Charles V.⁶,Huisman Menno V.¹

Affiliation:

1. Department of Thrombosis and Hemostasis, Leiden University Medical Center, the Netherlands (S.J.V.d.W., F.A.K., M.V.H.).

2. Division Cardiology, Duke University Medical Center, Durham, NC (R.D.L.).

3. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY (J.A.).

4. Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (P.R.).

5. Boehringer Ingelheim International GmbH, Ingelheim and Biberach, Germany (J.v.R., S.G., A.E.).

6. Emergency Medicine, Thomas Jefferson University and Sidney Kimmel Medical College, Philadelphia, PA (C.V.P.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

2. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

3. Hemorrhagic Shock

4. A specific antidote for dabigatran: functional and structural characterization

5. Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction of Upper Gastrointestinal Bleeding Risk With Proton Pump Inhibitor Therapy in Asian Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulant: A Nationwide Population-based Cohort Study;Clinical Gastroenterology and Hepatology;2024-05

2. Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding;European Journal of Anaesthesiology;2024-04-04

3. ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events;European Heart Journal Supplements;2024-04

4. Injectable‐Hydrogel‐Based Tissue Sealant for Hemostasis, Bacteria Inhibition, and Pro‐Angiogenesis in Organ Bleeding Wounds and Therapeutic Outcome Monitoring Via NIR‐II Optical Imaging;Advanced Healthcare Materials;2024-02-11

5. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02